Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study.

EBioMedicine - 1 Sept 2020

Nagpal Ravinder, Neth Bryan J, Wang Shaohua, Mishra Sidharth P, Craft Suzanne, Yadav Hariom

Abstract excerpt

BACKGROUND: Recently, we reported that patients with mild cognitive impairment (MCI) harbor specific signature of bacteria in their gut and that a modified Mediterranean ketogenic diet (MMKD) improves Alzheimer's disease (AD) markers in cerebrospinal fluid (CSF) and the signatures of gut bacteria. However, other microbial population such as gut fungi (mycobiome) in relation to MCI/AD pathology, gut bacteria and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diet, Ketogenic

Share to Gastrointestinal Microbiome

Share to Metagenome

Share to Metagenomics

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 32861197
DOI: 10.1016/j.ebiom.2020.102950
PMCID: PMC7475073

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study.PMID 32861197Read ↗

Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Dietary Pattern, Gut Microbiota, and Alzheimer’s DiseaseSemantic proximity Read ↗

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer’s DiseaseSemantic proximity Read ↗

The Microbiota–Gut–Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for InterventionsSemantic proximity Read ↗

Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model miceSemantic proximity Read ↗

Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s DiseaseSemantic proximity Read ↗

Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: a cross-sectional analysis from the SILCODE studySemantic proximity Read ↗

Comparative Metagenomics and Metabolomes Reveals Abnormal Metabolism Activity Is Associated with Gut Microbiota in Alzheimer’s Disease MiceSemantic proximity Read ↗

Gut Mycobiome Dysbiosis is Linked to Hypertriglyceridemia Among Home Dwelling Elderly DanesSemantic proximity Read ↗

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical ModelsSemantic proximity Read ↗

Differential Patterns of Gut and Oral Microbiomes in Hispanic Individuals with Cognitive ImpairmentSemantic proximity Read ↗

Enterotypes of the human gut mycobiomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.